Tech Company Financing Transactions
Nucleus Genomics Funding Round
Nucleus Genomics secured a $14 million Series A funding round on 1/30/2025. Investors included Founders Fund, Seven Seven Six and Neo.
Transaction Overview
Company Name
Announced On
1/30/2025
Transaction Type
Venture Equity
Amount
$14,000,000
Round
Series A
Investors
Proceeds Purpose
Nucleus will use funds to develop a centralized health platform that integrates data from diverse sources like blood tests, wearables and microbiome analysis.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
8000 Norman Center Drive
Bloomington, MN 55437
USA
Bloomington, MN 55437
USA
Phone
Undisclosed
Website
Email Address
Overview
Helping people live healthier, longer. We started Nucleus more than five years ago as a way to bring comprehensive genetic health insights to just about everybody. We've all got DNA, and DNA is the foundation of our health. We're building towards a world where no lives are taken by preventable diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Kian Sadeghi
Chief Scientific Officer
Lasse Folkersen
Browse more venture capital transactions:
Prev: 1/30/2025: Cedar Money venture capital transaction
Next: 1/30/2025: Rad AI venture capital transaction
Share this article
Where The Data Comes From
We document all VC transactions involving tech companies. VC investment data records reported here come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs